Acute thrombocytopenia due to meropenem: a case report

dc.contributor.authorDhande, Pritien_US
dc.contributor.authorDeshmukh, Shreyasen_US
dc.date.accessioned2020-04-23T07:59:29Z
dc.date.available2020-04-23T07:59:29Z
dc.date.issued2019-12
dc.description.abstractMeropenem is a broad spectrum antibacterial drug from the carbapenem family. It is commonly used as an empirical antimicrobial in severe infections like pneumonia, intra-abdominal infections, septicaemia, meningitis etc. Severe adverse effects with meropenem are rare (<1 %) which include hypersensitivity and hematologic adverse effects. In the literature, few cases have been reported of meropenem induced thrombocytopenia that has shown the immune mechanism by which thrombocytopenia occurs. Drug induced thrombocytopenia (DITP) can be a life threatening condition if not diagnosed and managed properly. As meropenem is being widely used in hospitals nowadays, it is important to be aware of the rare but serious adverse effects it causes.en_US
dc.identifier.affiliationsDepartment of Pharmacology, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, Maharashtra. Indiaen_US
dc.identifier.citationDhande Priti, Deshmukh Shreyas. Acute thrombocytopenia due to meropenem: a case report. International Journal of Basic & Clinical Pharmacology. 2019 Dec; 8(12): 2766-2768en_US
dc.identifier.issn2319-2003
dc.identifier.issn2279-0780
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/200467
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber12en_US
dc.relation.volume8en_US
dc.source.urihttps://dx.doi.org/10.18203/2319-2003.ijbcp20195294en_US
dc.subjectMeropenemen_US
dc.subjectBroad spectrum antibacterialen_US
dc.subjectDITPen_US
dc.titleAcute thrombocytopenia due to meropenem: a case reporten_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijbcp2019v8n12p2766.pdf
Size:
268.09 KB
Format:
Adobe Portable Document Format